Unibest

Pharmaceutical intermediates

Levocetirizine dihydrochloride Intermediates

1 pharmaceutical intermediate for Levocetirizine dihydrochloride. Indication: Respiratory hypersensitivity; Allergic dermatitis; Urticaria; Pruritus; Allergic rhinitis.

提交项目All intermediates

About Levocetirizine dihydrochloride

Originator
Ucb Inc.
Indication
Respiratory hypersensitivity; Allergic dermatitis; Urticaria; Pruritus; Allergic rhinitis
Approved Date
05/25/2007

Available intermediates

1 intermediate currently listed for Levocetirizine dihydrochloride. Request specifications, documentation or a quotation for any item below.

Levocetirizine dihydrochloride intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
2-chloroethoxyacetonitrile31250-08-5//

Other programs under L

(LCZ696)LanifibranorLapatinibLarotrectinibLasmiditanLazertinib MesylateLemborexantLenacapavir sodium

Building toward Levocetirizine dihydrochloride?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →